Here, we analysed the effects of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) supplementation on liver histology, adipokine profile and muscle function in an NAFLD model. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.